Micelle BioPharma Overview
- Founded
- 2006
- Status
- Private
- Employees
- 200
- Latest Deal Type
- Bankr. Admin/Reorg
Micelle BioPharma General Information
Description
Developer of lipid drug delivery technology designed to enhance the bioavailability of lipid and lipophilic active pharmaceutical ingredients. The company's lipid drug delivery technology focuses on developing and marketing a variety of products, enabling patients to improve the body's ability to break down and use lipophilic compounds such as fatty acids, hormones, several vitamins, and many active pharmaceutical ingredients.
Contact Information
Website
Formerly Known As
Sancilio & Company
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
- 3874 Fiscal Court
- Suite 100
- Riviera Beach, FL 33404
- United States
+1 (561) 000-0000
Micelle BioPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Bankruptcy: Admin/Reorg | 05-Nov-2018 | Completed | Bankruptcy: Admin/Reorg | |||
| 11. Later Stage VC | 19-Jan-2018 | 000 | 000.00 | Completed | Generating Revenue | |
| 10. IPO | 16-Sep-2016 | 000.00 | Cancelled | Generating Revenue | ||
| 9. Debt - General | 01-Feb-2016 | 0000 | 000.00 | Completed | Generating Revenue | |
| 8. Debt - General | 18-Dec-2014 | 000.00 | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series C) | 18-Jul-2014 | 0000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 6. Debt Repayment | 20-Dec-2013 | 000.00 | Completed | Generating Revenue | ||
| 5. Debt - General | 27-Aug-2013 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 4. Later Stage VC (Series B) | 01-Mar-2012 | $2M | $9.5M | 000.00 | Completed | Generating Revenue |
| 3. Later Stage VC (Series A) | 30-Jan-2012 | $7.5M | $7.5M | 000.00 | Completed | Generating Revenue |
Micelle BioPharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B | 00,000 | 00.000000 | 00 | 0000.00 | 0000.00 | 00 | 00.0 | 0.000 |
| Series A | 106,964 | $0.010000 | $71.78 | $71.78 | 1x | $0.72 | 42.79% |
Micelle BioPharma Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of lipid drug delivery technology designed to enhance the bioavailability of lipid and lipophilic active pharm
Biotechnology
Riviera Beach, FL
200
As of 2017
000.00
0000000000.
00000000
ng elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000 00000000
Morristown, NJ
0000
As of 0000
0.000
0000-00-00
000000&0
000000 0
ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
000000000000000
Plankstadt, Germany
000
As of 0000
00000 00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialMicelle BioPharma Competitors (16)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Capsugel | Formerly PE-Backed | Morristown, NJ | 0000 | 000000&0 | ||
| 000000 000000 | Venture Capital-Backed | Plankstadt, Germany | 000 | 00000 00000 | ||
| 0000000000000 0000 | Private Equity-Backed | Hunt Valley, MD | 000 | 00000 | 000000000 - | 00000 |
| 0000000 000000 | Formerly VC-backed | Balma, France | 0 | 00000 | 000000000 | 00000 |
| 0000 0000000000000 | Formerly PE-Backed | Whippany, NJ | 000 | 000000&0 |
Micelle BioPharma Executive Team (22)
Micelle BioPharma Board Members (17)
| Name | Representing | Role | Since |
|---|---|---|---|
| Harry Jacobson MD | Self | Chairman | 000 0000 |
| Jimmy Webb | Micelle BioPharma | Board Member | 000 0000 |
| John Mayo | Self | Board Member | 000 0000 |
| Rick Jacques JD | Micelle BioPharma | Board Member | 000 0000 |
| Van Hipp Jr. | Micelle BioPharma | Board Member | 000 0000 |
Micelle BioPharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial